ADAM12 and cancer: In normal brain tissues, ADAR2 edits nearly 100% of miR589-3p to target and reduce expression of disintegrin and metalloproteinase domain-containing protein 12 (ADAM12), a metalloprotease that promotes cancer metastasis.